REGN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Regeneron Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 632.9 USD 2.06% Market Closed

Market Cap: $66.4B

	Regeneron Pharmaceuticals Inc NASDAQ:REGN	US
	Olam Group Ltd SGX:VC2	SG
C	Christian Dior SE DUS:DIO	FR
	Emperador Inc SGX:EMI	PH
	Stepan Co NYSE:SCL	US
C	Cognizant Technology Solutions Corp XHAM:COZ	US
	Great Southern Bancorp Inc F:GS6	US
	Fugro NV OTC:FUGRF	NL
K	Konami Holdings Corp F:KOA	JP
G	G-III Apparel Group Ltd F:GI4	US
T	Toronto-Dominion Bank XMUN:TDB	CA

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

89% > 87%

Healthy Operating Margin

27%

Strong 3Y Average Operating Margin

31%

Declining Operating Margin

40% > 27%

Exceptional Net Margin

31%

Strong 3Y Average Net Margin

32%

Declining Net Margin

34% > 31%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

26%

Free Cash Flow Margin is Increasing

20% > 26%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

22% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.